Skip to main content
. 2019 Aug 8;19:63. doi: 10.1186/s12880-019-0355-z

Table 1.

Characteristics of patients in the primary and validation cohorts

Characteristic Primary cohort Validation cohort
CAP Pulmonary TB p value CAP Pulmonary TB p-value
Gender, No. (%) 0.151 0.047*
 Male 25 (54.35) 26 (65.00) 8 (50.00) 11 (84.62)
 Female 21 (45.65) 14 (35.00) 8 (50.00) 2 (15.38)
Age, mean ± SD, years 4.51 ± 3.44 3.41 ± 3.66 0.181 2.69 ± 3.10 1.77 ± 1.62 0.332
Hemoptysis, No. (%) 0.083
 + 0 (0.0) 3 (7.50) 0 (0.00) 0 (0.00)
 - 46 (100.0) 37 (92.50) 16 (100.00) 13 (100.00)
Cough, No. (%) 0.324 0.82
 - 2 (4.35) 4 (10.00) 0 (0.00) 3 (23.08)
 + 44 (95.65) 36 (90.00) 16 (100.00) 10 (76.92)
fever, No. (%) 0.143
 - 1 (2.17) 4 (10.00) 9 (56.25) 5 (38.46)
 + 45 (97.83) 36 (90.00) 7 (43.75) 8 (61.54)
Expectoration, No. (%) 0.129 0.358
 - 20 (43.48) 24 (60.00) 6 (37.50) 6 (46.15)
 + 26 (56.52) 16 (40.00) 10 (62.50) 7 (53.85)
duration of fever (days) <0.001*** <0.001
 <10 43 (93.48) 15 (37.50) 15 (93.75) 3 (23.08)
 ≥10 3 (6.52) 25 (62.50) 1 (6.25) 10 (76.92)
WBC (*10^9/L), No. (%) 0.247 0.264
Median(IQR) 8.42 (6.70-10.16) 8.40 (7.10-11.41) 14.98 (14.18-17.26) 16.89 (16.30-19.77)
Normal 27 (58.70) 20 (50.00) 5 (31.25) 5 (38.46)
Abnormal 19 (41.30) 20 (50.00) 11 (68.75) 8 (61.54)
CRP (mg/L), No. (%) 0.365 0.381
Median (IQR) 23.30 (11.53-56.25) 15.70 (9.44-33.88) 28.25 (16.00-71.75) 29.00 (14.00-53.60)
Normal 7 (15.22) 8 (20.00) 1 (6.25) 3 (23.08)
Abnormal 39 (84.78) 32 (80.00) 15 (93.75) 10 (76.92)
Radiomic signature1 median 0.53 (0.32 to 0.86) <0.001*** 0.53 (0.33 to 0.74) 0.018*
Radiomic signature2 median 0.54 (0.12 to 0.98) <0.001*** 0.54 (0.20 to 1.26) <0.001***

NOTE. The p-value was derived from univariable association analyses of each characteristic and of the two diseases. * denotes p-value< 0.05; ** denotes p-value< 0.01; *** denotes p-value<0.001

Abbreviations: WBC white blood cell, CRP C-reaction protein